These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26357839)

  • 1. Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment.
    Perut F; Carta F; Bonuccelli G; Grisendi G; Di Pompo G; Avnet S; Sbrana FV; Hosogi S; Dominici M; Kusuzaki K; Supuran CT; Baldini N
    Expert Opin Ther Targets; 2015; 19(12):1593-605. PubMed ID: 26357839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of carbonic anhydrase IX decreases cell proliferation and induces ceramide-mediated apoptosis in human cancer cells.
    Cianchi F; Vinci MC; Supuran CT; Peruzzi B; De Giuli P; Fasolis G; Perigli G; Pastorekova S; Papucci L; Pini A; Masini E; Puccetti L
    J Pharmacol Exp Ther; 2010 Sep; 334(3):710-9. PubMed ID: 20519553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
    Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
    Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity.
    Suthar SK; Bansal S; Lohan S; Modak V; Chaudhary A; Tiwari A
    Eur J Med Chem; 2013 Aug; 66():372-9. PubMed ID: 23827177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hypoxia-inducible carbonic anhydrase-IX enhances hexokinase II inhibitor-induced hepatocellular carcinoma cell apoptosis.
    Yu SJ; Yoon JH; Lee JH; Myung SJ; Jang ES; Kwak MS; Cho EJ; Jang JJ; Kim YJ; Lee HS
    Acta Pharmacol Sin; 2011 Jul; 32(7):912-20. PubMed ID: 21666701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing carbonic anhydrase inhibitors for the treatment of breast cancer.
    Supuran CT; Winum JY
    Expert Opin Drug Discov; 2015 Jun; 10(6):591-7. PubMed ID: 25891195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors.
    Cecchi A; Hulikova A; Pastorek J; Pastoreková S; Scozzafava A; Winum JY; Montero JL; Supuran CT
    J Med Chem; 2005 Jul; 48(15):4834-41. PubMed ID: 16033263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
    Puccetti L; Fasolis G; Cecchi A; Winum JY; Gamberi A; Montero JL; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 May; 15(9):2359-64. PubMed ID: 15837325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors.
    Supuran CT
    Expert Opin Investig Drugs; 2018 Dec; 27(12):963-970. PubMed ID: 30426805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX.
    Pastorekova S; Casini A; Scozzafava A; Vullo D; Pastorek J; Supuran CT
    Bioorg Med Chem Lett; 2004 Feb; 14(4):869-73. PubMed ID: 15012984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors.
    Morris JC; Chiche J; Grellier C; Lopez M; Bornaghi LF; Maresca A; Supuran CT; Pouysségur J; Poulsen SA
    J Med Chem; 2011 Oct; 54(19):6905-18. PubMed ID: 21851094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase inhibitors: transepithelial transport of thioureido sulfonamide inhibitors of the cancer-associated isozyme IX is dependent on efflux transporters.
    Vullo D; Steffansen B; Brodin B; Supuran CT; Scozzafava A; Nielsen CU
    Bioorg Med Chem; 2006 Apr; 14(7):2418-27. PubMed ID: 16321542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective carbonic anhydrase IX inhibitors based on coumarin scaffold as promising antimetastatic agents: WO2012070024.
    Carradori S
    Expert Opin Ther Pat; 2013; 23(6):751-6. PubMed ID: 23387899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic secondary sulfonamides: unusually good inhibitors of cancer-related carbonic anhydrase enzymes.
    Moeker J; Peat TS; Bornaghi LF; Vullo D; Supuran CT; Poulsen SA
    J Med Chem; 2014 Apr; 57(8):3522-31. PubMed ID: 24689792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors.
    Dubois L; Douma K; Supuran CT; Chiu RK; van Zandvoort MA; Pastoreková S; Scozzafava A; Wouters BG; Lambin P
    Radiother Oncol; 2007 Jun; 83(3):367-73. PubMed ID: 17502120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors.
    Touisni N; Maresca A; McDonald PC; Lou Y; Scozzafava A; Dedhar S; Winum JY; Supuran CT
    J Med Chem; 2011 Dec; 54(24):8271-7. PubMed ID: 22077347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH.
    Svastová E; Hulíková A; Rafajová M; Zat'ovicová M; Gibadulinová A; Casini A; Cecchi A; Scozzafava A; Supuran CT; Pastorek J; Pastoreková S
    FEBS Lett; 2004 Nov; 577(3):439-45. PubMed ID: 15556624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX.
    Alterio V; Vitale RM; Monti SM; Pedone C; Scozzafava A; Cecchi A; De Simone G; Supuran CT
    J Am Chem Soc; 2006 Jun; 128(25):8329-35. PubMed ID: 16787097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides.
    Cecchi A; Taylor SD; Liu Y; Hill B; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5192-6. PubMed ID: 16203142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.